Cluzeau, T., Moreilhon, C., Mounier, N., Karsenti, J., Gastaud, L., Garnier, G., . . . Raynaud, S. (2013). Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine. Nature Publishing Group.
Dyfyniad Arddull ChicagoCluzeau, T., et al. Total Genomic Alteration As Measured By SNP-array-based Molecular Karyotyping Is Predictive of Overall Survival in a Cohort of MDS or AML Patients Treated With Azacitidine. Nature Publishing Group, 2013.
Dyfyniad MLACluzeau, T., et al. Total Genomic Alteration As Measured By SNP-array-based Molecular Karyotyping Is Predictive of Overall Survival in a Cohort of MDS or AML Patients Treated With Azacitidine. Nature Publishing Group, 2013.